Gordian Surgical

Company Overview

Snapshot

Founded in November 2012 by Zvi Pe'er, Gordian Surgical operates with 1–10 employees. The company has raised a total of $8.7 million across 6 funding rounds from 6 investors. In December 2016, Gordian Surgical secured FDA clearance for its TroClose1200 device.

Business overview

Gordian Surgical develops medical devices for laparoscopic procedures, focusing on integrated port closure systems. Its core product, the TroClose 1200, is designed to simplify and secure the process of opening and suturing the abdominal wall during surgery. The device efficiently inserts absorbable sutures into the peritoneal tissue at the beginning of a procedure, allowing surgeons to close the fascia by tying the sutures after cannula removal. Gordian Surgical serves the healthcare industry, specifically targeting surgeons, hospitals, and clinics with its surgical instruments and minimally invasive solutions.

Strategic signal

In October 2019, Gordian Surgical raised $3 million in funding, indicating continued investor confidence and support for the development and commercialization of its surgical closure system. This capital infusion suggests the company is well-positioned to advance its market penetration and product innovation within the medical device sector, particularly for laparoscopic procedures.

Company Intelligence Q&A

What is Gordian Surgical's primary product?

Gordian Surgical's primary product is the TroClose 1200, an integrated port closure system designed for laparoscopic procedures.

When was Gordian Surgical founded?

Gordian Surgical was founded in November 2012.

Has Gordian Surgical received any regulatory clearances for its products?

Yes, Gordian Surgical received FDA clearance for its TroClose1200 device in December 2016.

Which investor participated in Gordian Surgical's Seed round?

The Trendlines Group participated in Gordian Surgical's Seed round in January 2013.